APOE and Alzheimer disease: After stratifying the aMCI due to AD group based on APOE ε4 status, this positive association remained significant only in the APOE ε4 carriers (β = 0.64, p = .042), and although it was still present, it was not significant in APOE ε4 non-carriers (β = 0.49, p = .136).